Abstract
Endothelium lining the luminal surface of blood vessels is the key target and barrier for vascular drug delivery. Nanocarriers coated with antibodies or affinity peptides that bind specifically to endothelial surface determinants provide targeted delivery of therapeutic cargoes to these cells. Endothelial targeting consists of several phases including circulation in the bloodstream, anchoring on the endothelial surface and, in some cases, intracellular uptake and trafficking of the internalized materials. Dynamic parameters of the vasculature including the blood hydrodynamics as well as surface density, accessibility, membrane mobility and clustering of target determinants modulate these phases of the targeting, especially anchoring to endothelium. Further, such controlled parameters of design of drug nanocarriers such as affinity, surface density and epitope specificity of targeting antibodies, carrier size and shape also modulate endothelial targeting and resultant sub-cellular addressing. This article reviews experimental and computational approaches for analysis of factors modulating targeting nanocarriers to the endothelial cells.
Keywords: Antibody surface density, carrier concentration, cell adhesion molecules, endothelium, hydrodynamics, nanocarriers, optimization, targeted drug delivery, polimersomes, biotherapeutics
Current Drug Metabolism
Title: Dynamic Factors Controlling Targeting Nanocarriers to Vascular Endothelium
Volume: 13 Issue: 1
Author(s): Vladimir R. Muzykantov, Ravi Radhakrishnan and David M. Eckmann
Affiliation:
Keywords: Antibody surface density, carrier concentration, cell adhesion molecules, endothelium, hydrodynamics, nanocarriers, optimization, targeted drug delivery, polimersomes, biotherapeutics
Abstract: Endothelium lining the luminal surface of blood vessels is the key target and barrier for vascular drug delivery. Nanocarriers coated with antibodies or affinity peptides that bind specifically to endothelial surface determinants provide targeted delivery of therapeutic cargoes to these cells. Endothelial targeting consists of several phases including circulation in the bloodstream, anchoring on the endothelial surface and, in some cases, intracellular uptake and trafficking of the internalized materials. Dynamic parameters of the vasculature including the blood hydrodynamics as well as surface density, accessibility, membrane mobility and clustering of target determinants modulate these phases of the targeting, especially anchoring to endothelium. Further, such controlled parameters of design of drug nanocarriers such as affinity, surface density and epitope specificity of targeting antibodies, carrier size and shape also modulate endothelial targeting and resultant sub-cellular addressing. This article reviews experimental and computational approaches for analysis of factors modulating targeting nanocarriers to the endothelial cells.
Export Options
About this article
Cite this article as:
R. Muzykantov Vladimir, Radhakrishnan Ravi and M. Eckmann David, Dynamic Factors Controlling Targeting Nanocarriers to Vascular Endothelium, Current Drug Metabolism 2012; 13 (1) . https://dx.doi.org/10.2174/138920012798356916
DOI https://dx.doi.org/10.2174/138920012798356916 |
Print ISSN 1389-2002 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5453 |
![](/images/wayfinder.jpg)
- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Autonomic Nervous System in Viral Myocarditis: Pathophysiology and Therapy
Current Pharmaceutical Design Point of NO Return for Nitrergic Nerves in Diabetes: A New Insight into Diabetic Complications
Current Pharmaceutical Design Pharmacotherapy of Abdominal Aortic Aneurysms
Current Vascular Pharmacology Antiplatelet Therapy And Percutaneous Coronary Interventions
Current Cardiology Reviews Global Cerebral Ischemia: Synaptic and Cognitive Dysfunction
Current Drug Targets The Role of microRNA-126 in Vascular Homeostasis
Current Vascular Pharmacology Autophagy Dysfunction and its Link to Alzheimer’s Disease and Type II Diabetes Mellitus
CNS & Neurological Disorders - Drug Targets Tandem Pore Domain K Channels An Important Site of Volatile Anesthetic Action
Current Drug Targets Peripartum Cardiomyopathy: Current State of Knowledge, New Developments and Future Directions
Current Cardiology Reviews Toward Greater Insights on Applications of Modeling and Simulation in Pregnancy
Current Drug Metabolism Good at Heart: Preserving Cardiac Metabolism during aging
Current Diabetes Reviews The Malignant Obesity Hypoventilation Syndrome (MOHS)
Current Respiratory Medicine Reviews Role of Transcranial Doppler Ultrasonography in Cerebrovascular Disease
Recent Patents on CNS Drug Discovery (Discontinued) Morphological and Molecular Changes of the Myocardium After Left Ventricular Mechanical Support
Current Cardiology Reviews Recent Advancements in Diagnosis and Therapy of Liver Cirrhosis
Current Drug Targets Different Generations of Type-B Monoamine Oxidase Inhibitors in Parkinson’s Disease: From Bench to Bedside
Current Neuropharmacology Apoptosis in Atherosclerosis: Virtue or Vice
Current Cardiology Reviews The Use of Human Albumin for the Treatment of Ascites in Patients with Liver Cirrhosis: Item of Safety, Facts, Controversies and Perspectives
Current Drug Safety How Drugs Influencing Central Blood Pressure Prevent Atherosclerosis Complications?
Current Pharmaceutical Biotechnology Angiotensin II, Cell Proliferation and Angiogenesis Regulator: Biologic and Therapeutic Implications in Cancer
Current Vascular Pharmacology